Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ann Intern Med. 2003 Feb 4;138(3):187-90.

Treatment of chronic hepatitis C in a state correctional facility.

Author information

  • 1Rhode Island Department of Corrections, 39 Howard Avenue, Cranston, RI 02920, USA.

Erratum in

  • Ann Intern Med. 2003 Oct 7;139(7):605.

Abstract

BACKGROUND:

Approximately 1 in 4 of the nearly 2 million individuals in state and federal correctional facilities are infected with hepatitis C virus (HCV). Currently, there are few reports of treatment outcomes of this common infection in this setting.

OBJECTIVE:

To describe HCV therapy in the incarcerated setting.

DESIGN:

Retrospective, descriptive observational study.

SETTING:

Rhode Island Department of Corrections, Cranston, Rhode Island.

PATIENTS:

93 inmates with chronic HCV infection.

INTERVENTION:

Interferon-alpha with ribavirin.

MEASUREMENTS:

HCV RNA levels 6 months after treatment.

RESULTS:

Response rates are similar to previously published rates achieved in the community; 63% (50 of 79) of patients achieved viral clearance after 6 months of therapy, and 46% (26 of 57) achieved sustained response 6 months after treatment.

CONCLUSION:

The incarcerated population (which is disproportionately affected by addiction and psychiatric illness) can be effectively treated for HCV infection with interferon and ribavirin. The correctional setting may provide an opportunity to safely treat patients with these two challenging comorbid conditions.

Comment in

PMID:
12558357
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk